Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 148560quant ESG Integration Strategy Fund
Disclosed for 71 months, Nov 2020 to Sep 2026.
Portfolio value
₹200 Cr
up ₹8.5 Cr vs Nov 2023
- Stocks held
- 15
- unchanged
- Top 10 weight
- 74.0%
- of the portfolio in its ten largest
- Largest position
quant ESG Integration Strategy Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In December 2023 it disclosed 15 stocks worth ₹200 Cr, up ₹8.5 Cr from Nov 2023. Its largest positions were Reliance Industries Limited (10.1%), RBL Bank Limited (9.7%), Jio Financial Services Limited (9.6%); the ten largest together made up 74.0% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 26.4% of its equity. Cash and debt stood at 1.3%. Compared with Nov 2023 the fund entered 6 new stocks and exited 6.
Against 229 other Sectoral / Thematic funds
Concentration
96%
Top-10 weight is higher than 96% of peers
Breadth
2%
Holds more stocks than 2% of peers
Cash
14%
Holds more cash than 14% of peers
What these mean: concentration · cash
Holdings in December 2023
Download CSVEvery line the fund disclosed, with the change against Nov 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Reliance Industries Limited | 10.07% | up 0.27 pts | ₹20.2 Cr | up ₹1.4 Cr | Added |
| RBL Bank Limited | 9.65% | up 1.24 pts | ₹19.3 Cr | up ₹3.2 Cr | Added |
| Jio Financial Services Limited | 9.61% | down 0.28 pts | ₹19.3 Cr | up ₹29 L | Added |
| Jindal Steel & Power Limited | 8.59% | up 0.54 pts | ₹17.2 Cr | up ₹1.8 Cr | Added |
| Indian Bank | 6.93% | up 6.93 pts | ₹13.9 Cr | up ₹13.9 Cr | New |
| GlaxoSmithKline Pharmaceuticals Limited | 6.92% | up 6.92 pts | ₹13.9 Cr | up ₹13.9 Cr | New |
| Aster DM Healthcare Limited | 6.85% | up 0.17 pts | ₹13.7 Cr | up ₹92 L | Added |
| Sun Pharmaceutical Industries Limited | 5.56% | down 0.86 pts | ₹11.1 Cr | down ₹1.2 Cr | Trimmed |
| 91 Days Treasury Bill 14-Mar-2024 Debt | 4.92% | up 4.92 pts | ₹9.9 Cr | up ₹9.9 Cr | New |
| Aurobindo Pharma Limited 25/01/2024 Derivative | 4.92% | up 4.92 pts | ₹9.8 Cr | up ₹9.8 Cr | New |
| Lupin Limited | 4.62% | down 0.05 pts | ₹9.3 Cr | up ₹29 L | Added |
| Life Insurance Corporation Of India | 4.57% | up 3.68 pts | ₹9.2 Cr | up ₹7.5 Cr | Added |
| Aurobindo Pharma Limited | 3.57% | down 0.01 pts | ₹7.2 Cr | up ₹28 L | Added |
| India Shelter Finance Corporation Limited | 3.55% | up 3.55 pts | ₹7.1 Cr | up ₹7.1 Cr | New |
| Britannia Industries Limited 25/01/2024 Derivative | 3.19% | up 3.19 pts | ₹6.4 Cr | up ₹6.4 Cr | New |
| Britannia Industries Limited | 2.66% | up 2.66 pts | ₹5.3 Cr | up ₹5.3 Cr | New |
| GAIL (India) Limited 25/01/2024 Derivative | 2.61% | up 2.61 pts | ₹5.2 Cr | up ₹5.2 Cr | New |
| Jubilant Pharmova Limited | 2.18% | up 2.18 pts | ₹4.4 Cr | up ₹4.4 Cr | New |
| Godrej Consumer Products Limited 25/01/2024 Derivative | 1.51% | up 1.51 pts | ₹3 Cr | up ₹3 Cr | New |
| Bandhan Bank Limited | 1.20% | up 1.20 pts | ₹2.4 Cr | up ₹2.4 Cr | New |
| Cash, TREPS & receivables | −3.67% | down 5.45 pts | −₹7.3 Cr | down ₹10.8 Cr | Trimmed |
What changed, Nov 2023 to Dec 2023
New New positions (6)
- Indian Bank6.9% · ₹13.9 Cr
- GlaxoSmithKline Pharmaceuticals Limited6.9% · ₹13.9 Cr
- India Shelter Finance Corporation Limited3.5% · ₹7.1 Cr
- Britannia Industries Limited2.7% · ₹5.3 Cr
- Jubilant Pharmova Limited2.2% · ₹4.4 Cr
- Bandhan Bank Limited1.2% · ₹2.4 Cr
Exited Exited (6)
- Tata Communications Limitedwas 8.0% · ₹15.4 Cr
- Persistent Systems Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Nov 2023, the weight rose most in Banks (+10.1 pts) and Pharmaceuticals & Biotechnology (+8.1 pts), and fell most in Telecom - Services (−10.0 pts) and IT - Software (−5.8 pts).
- Banks10.5% → 20.6%+10.1 pts
- Pharmaceuticals & Biotechnology18.3% → 26.4%+8.1 pts
- Insurance1.1% → 5.3%+4.2 pts
- Food Products0.0% → 3.1%new+3.1 pts
- Finance12.3% → 15.2%+2.9 pts
- Telecom - Services10.0% → 0.0%exited−10.0 pts
- IT - Software5.8% → 0.0%exited−5.8 pts
- Construction5.5% → 0.0%exited−5.5 pts
- Financial Technology (fintech)4.0% → 0.0%exited−4.0 pts
- Power1.8% → 0.0%exited−1.8 pts
- Petroleum Products12.2% → 11.6%−0.6 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2020 | Dec 2022 | Jun 2023 | Sep 2023 | Nov 2023 | Dec 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 32.0% | — | 23.4% | 11.3% | 18.3% | 26.4% |
| Banks | — | 24.4% | 13.2% | 11.2% | 10.5% | 20.6% |
| Finance | — | 1.3% | — | 12.3% | 12.3% | 15.2% |
| Petroleum Products | — | 8.1% | 11.4% | 15.9% | 12.2% | 11.6% |
| Ferrous Metals | — | 5.9% | 6.3% | 10.4% | 10.0% | 9.9% |
| Healthcare Services | 8.9% | 3.2% | — | 7.4% | 8.3% | 7.9% |
| Insurance | 2.8% | 6.5% | — | — | 1.1% | 5.3% |
| Food Products | 1.6% | 8.2% | 12.2% | — | — | 3.1% |
Allocation in Dec 2023change vs Nov 2023
- Pharmaceuticals & Biotechnology (5)26.4%▲ 8.1 pts
- Banks (3)20.6%▲ 10.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Dec 2023
1.3%
▼ 0.5 pts vs Nov 2023
- Cash alone
- −3.7%
- cash and net receivables
- A year earlier
- 0.1%
- Dec 2022 · now ▲ 1.2 pts
- Last 12 months
- 0.1% – 17.8%
- lowest to highest · record 17.8% in Aug 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.